StockData
Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc. (ORGO) stock

ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$0.79−0.06 (-7.50%)

Close on Nov 19, 2026Market cap $101.55MP/E –Yield –

Organogenesis net income

Net income is the profit left for shareholders after every expense, interest and tax.

Organogenesis's net income for the twelve months ending Jun 30, 2026 was -$84.16M. For fiscal 2025 it was $37.03M, up 4201.0% from the year before. The highest annual figure on record is $94.20M in fiscal 2021.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$37.03M+4201.0%
FY2024Dec 31, 2024$861.00K-82.6%
FY2023Dec 31, 2023$4.95M-68.2%
FY2022Dec 31, 2022$15.53M-83.5%
FY2021Dec 31, 2021$94.20M+446.6%
FY2020Dec 31, 2020$17.23M–
FY2019Dec 31, 2019-$38.71M–
FY2018Dec 31, 2018-$64.83M–
FY2017Dec 31, 2017-$8.39M–
FY2016Dec 31, 2016-$16.99M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$96.27M–
Q1 FY2026Mar 31, 2026-$53.16M–
Q4 FY2025Dec 31, 2025$43.70M+469.5%
Q3 FY2025Sep 30, 2025$21.57M+74.9%
Q2 FY2025Jun 30, 2025-$9.39M–
Q1 FY2025Mar 31, 2025-$18.84M–
Q4 FY2024Dec 31, 2024$7.67M–
Q3 FY2024Sep 30, 2024$12.33M+289.4%
Q2 FY2024Jun 30, 2024-$17.04M-420.6%
Q1 FY2024Mar 31, 2024-$2.10M–
Q4 FY2023Dec 31, 2023-$568.00K-107.6%
Q3 FY2023Sep 30, 2023$3.17M+1373.0%
Q2 FY2023Jun 30, 2023$5.32M-39.2%
Q1 FY2023Mar 31, 2023-$2.97M–
Q4 FY2022Dec 31, 2022$7.49M-85.3%
Q3 FY2022Sep 30, 2022$215.00K-98.3%
Q2 FY2022Jun 30, 2022$8.74M-57.7%
Q1 FY2022Mar 31, 2022-$913.00K-109.2%
Q4 FY2021Dec 31, 2021$51.00M+178.4%
Q3 FY2021Sep 30, 2021$12.58M-39.4%
Q2 FY2021Jun 30, 2021$20.69M–
Q1 FY2021Mar 31, 2021$9.94M–
Q4 FY2020Dec 31, 2020$18.32M–
Q3 FY2020Sep 30, 2020$20.76M–
Q2 FY2020Jun 30, 2020-$5.17M–
Q1 FY2020Mar 31, 2020-$16.31M–
Q4 FY2019Dec 31, 2019-$2.65M–
Q3 FY2019Sep 30, 2019-$10.74M–
Q2 FY2019Jun 30, 2019-$9.65M–
Q1 FY2019Mar 31, 2019-$15.67M–
Q4 FY2018Dec 31, 2018-$9.26M–
Q3 FY2018Sep 30, 2018-$13.08M–
Q2 FY2018Jun 30, 2018-$20.01M-64648.4%
Q1 FY2018Mar 31, 2018-$22.49M-1088.5%
Q4 FY2017Dec 31, 2017-$4.43M–
Q3 FY2017Sep 30, 2017-$5.40M–
Q2 FY2017Jun 30, 2017$31.00K–
Q1 FY2017Mar 31, 2017$2.28M–
Q4 FY2016Dec 31, 2016-$178.16K–
Q3 FY2016Sep 30, 2016-$14.49K–

More Organogenesis figures

See a number that looks wrong?